All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AKERO THERAPEUTICS, INC. Last Reported: 11/30/2021 Stock Symbol: AKRO

Business Address

601 GATEWAY BOULEVARD, SUITE 350

SOUTH SAN FRANCISCO , CA US 94080

Mailing Address

601 GATEWAY BOULEVARD, SUITE 350

SOUTH SAN FRANCISCO , CA US 94080
Phone Number: 650-487-6488 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017
Cash and Cash Equivalents $164,935,000.00 $157,538,000.00 $187,960,000.00 $187,242,000.00 $192,679,000.00 $63,247,000.00 $47,245,000.00 $64,788,000.00 $147,835,000.00 $162,654,000.00 -- $75,975,000.00 -- -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $6,726,000.00 $6,194,000.00 $5,792,000.00 $2,958,000.00 $6,163,000.00 $10,360,000.00 $933,000.00 $1,649,000.00 $2,238,000.00 $454,000.00 -- $1,156,000.00 -- -- -- --
Total Current Assets $221,807,000.00 $236,222,000.00 $255,776,000.00 $271,345,000.00 $298,033,000.00 $113,193,000.00 $126,218,000.00 $138,049,000.00 $150,073,000.00 $163,108,000.00 -- $77,131,000.00 -- -- -- --
Property Plant and Equipement $101,000.00 $110,000.00 $120,000.00 $131,000.00 $137,000.00 -- -- -- -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $114,000.00 $115,000.00 $115,000.00 $201,000.00 $156,000.00 $865,000.00 $177,000.00 $69,000.00 $10,000.00 -- -- $20,000.00 -- -- -- --
Total Assets $223,533,000.00 $238,009,000.00 $257,623,000.00 $273,339,000.00 $300,036,000.00 $114,058,000.00 $126,621,000.00 $138,118,000.00 $150,143,000.00 $163,168,000.00 -- $77,151,000.00 -- -- -- --
Accounts Payable $6,784,000.00 $2,307,000.00 $4,605,000.00 $3,428,000.00 $4,636,000.00 $2,536,000.00 $1,535,000.00 $947,000.00 $93,000.00 $3,248,000.00 -- $1,373,000.00 -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $24,905,000.00 $17,876,000.00 $11,603,000.00 $14,627,000.00 $13,578,000.00 $10,395,000.00 $8,298,000.00 $9,392,000.00 $6,759,000.00 $4,779,000.00 -- $2,342,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $476,521,000.00 $473,688,000.00 $470,635,000.00 $468,238,000.00 $466,254,000.00 $261,983,000.00 $260,481,000.00 $259,049,000.00 $258,090,000.00 $257,541,000.00 -- $36,646,000.00 -- -- -- --
Accumulated Other Comprehensive Loss $-17,000.00 $-9,000.00 $-2,000.00 $-3,000.00 $16,000.00 $90,000.00 $45,000.00 $-6,000.00 -- -- -- -- -- -- -- --
Accumulated Deficit $-277,880,000.00 $-253,550,000.00 $-224,617,000.00 $-209,527,000.00 $-179,816,000.00 $-158,413,000.00 $-142,206,000.00 $-130,320,000.00 $-114,709,000.00 $-99,155,000.00 -- $-86,565,000.00 -- -- -- --
Total Stockholders' Equity $198,628,000.00 $220,133,000.00 $246,020,000.00 $258,712,000.00 $286,458,000.00 $103,663,000.00 $118,323,000.00 $128,726,000.00 $143,384,000.00 $158,389,000.00 $-55,066,000.00 $-49,919,000.00 $-25,093,000.00 $-13,728,000.00 $-4,985,000.00 $-4,564,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $223,533,000.00 $238,009,000.00 $257,623,000.00 $273,339,000.00 $300,036,000.00 $114,058,000.00 $126,621,000.00 $138,118,000.00 $150,143,000.00 $163,168,000.00 -- $77,151,000.00 -- -- -- --

Statement of Operations

Date 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $54,048,000.00 $34,578,000.00 $10,602,000.00 $64,916,000.00 $17,379,000.00 $13,037,000.00 $8,791,000.00 $37,046,000.00 $23,908,000.00 $5,960,000.00 $4,063,000.00 $11,882,000.00 $9,899,000.00 $8,646,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Loss from Operations $-24,353,000.00 $-44,094,000.00 $-15,128,000.00 $-80,154,000.00 $-50,371,000.00 $-16,454,000.00 $-12,379,000.00 $-45,651,000.00 $-29,430,000.00 $-13,121,000.00 $-5,512,000.00 $-13,778,000.00 $-10,810,000.00 $-9,083,000.00 -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 150,000,000 -- 75,000,000 -- -- -- --
Common Stock Shares Outstanding 34,875,302 34,840,782 34,770,319 34,741,649 34,720,675 28,683,679 28,671,222 28,567,837 28,558,653 28,555,379 -- 238,986 -- -- -- --
Common Stock Value $4,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 $3,000.00 -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- $36.00 -- -- -- -- -- -- -- -- -- --
Copyright 2022 PursePoor.com